$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
玻玛西林联合含芳香酶抑制剂的治疗效果
2025-10-19 11:44:20
Check Details
玻玛西林的出现,使乳腺癌患者有了新选择
2025-10-19 11:44:20
Check Details
乳腺癌脑转移适合使用帕博西尼进行治疗吗?
2025-10-19 11:44:20
Check Details
乳腺癌患者使用玻玛西林治疗可以使肿瘤缩小吗?
2025-10-19 11:44:20
Check Details
用帕博西尼治疗转移性乳腺癌多久才有效果?
2025-10-19 11:44:20
Check Details
乳腺癌靶向药帕博西尼怎么正确服用?
2025-10-19 11:44:20
Check Details
乳腺癌患者使用帕博西尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
乳腺癌患者服用玻玛西林的禁忌和注意事项
2025-10-19 11:44:20
Check Details
乳腺癌治疗药物玻玛西林在中国获批上市了吗?
2025-10-19 11:44:20
Check Details
玻玛西林治疗HR + / HER2-转移性乳腺癌的安全性和有效性
2025-10-19 11:44:20
Check Details
乳腺癌患者可以服用甲氨蝶呤片进行治疗吗?
2025-10-19 11:44:20
Check Details
甲氨蝶呤片在乳腺癌中的用法用量
2025-10-19 11:44:20
Check Details
1
2
...
2000
2001
2002
2003
2004
2005
2006
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
2
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
3
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
4
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
5
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
6
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
7
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
8
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
9
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
10
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
11
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
12
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity